A lot of data had been produced in the biomedical sciences, and the US National Institute of Health has picked Philip Bourne, a professor and an associate vice chancellor of innovation and industry alliance at the University of California, San Diego, to head up an effort at the agency to make the best use of such big data. Bourne is to be the first associate director for data science at the agency.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Money for Big Data

Just One for You

Billion More?

This Week in Nucleic Acids Research: Researchers describe a new method to find large-scale structural variants in cancer genomes, a glimpse at an approach for profiling miRNAs in tumor samples from TCGA, and more.

Intellia Therapeutics has raised $70 million, becoming the latest firm leveraging the gene editing technology to haul in a gob of cash.

Now going beyond reporting fetal aneuploidies, NIPTs may be providing too much information that may be useless, some doctors and genetic counselor say.

A group of organizations in the UK say that there needs to be discussions about the use of technologies such as CRISPR/Cas-9 for human germline editing.